We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer Agrees To $57M Deal To End Yaz Blood Clot Suits

Law360, Philadelphia (August 4, 2015, 11:36 AM EDT) -- Bayer Corp. has agreed to pay nearly $57 million to end a series of lawsuits across multiple federal and state jurisdictions over allegations that use of its birth control pills Yaz, Yasmin and Ocella resulted in strokes and heart attacks.

The proposed settlement fund, announced late Monday, would put to rest claims pending as part of a multidistrict litigation program in Illinois federal court, as well as suits that have been filed in Pennsylvania, New Jersey and California state courts.

“In light of the significant costs and delay that would result in further protracted litigation, the settlement program will ensure that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS